HOSPICES CIVILS DE LYON
Pregnant Women Vaccinated Against Covid-19.
- Conditions
- Pregnant Women Vaccinated Against Covid-19
- Interventions
- Other: Patient's consentOther: Inclusion formOther: Adverse reaction report form.Diagnostic Test: Follow-up report form.
- First Posted Date
- 2021-07-12
- Last Posted Date
- 2023-03-27
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 1393
- Registration Number
- NCT04957953
- Locations
- 🇫🇷
Service Hospitalo-Universitaire de Pharmacotoxicologie, Lyon, France
HEmiplegia Arrhythmia Retrospective Trial
- Conditions
- Alternating Hemiplegia of Childhood
- Interventions
- Other: Recording of clinical parameters and electrocardiogram parameters
- First Posted Date
- 2021-06-30
- Last Posted Date
- 2023-02-22
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 20
- Registration Number
- NCT04944927
- Locations
- 🇫🇷
Department of Clinical Epileptology, Sleep Disorders and Functional Neurology in Children, Hôpital Femme Mère Enfant, University Hospitals of Lyon (Hospices Civils de Lyon), Bron, France
Impact of the Covid-19 on Respiratory Syncytial Virus (RSV) Epidemic
- Conditions
- RSV Infection
- Interventions
- Other: Medical records analysisOther: Comparison of cohorts
- First Posted Date
- 2021-06-29
- Last Posted Date
- 2022-05-02
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 600
- Registration Number
- NCT04944160
- Locations
- 🇫🇷
Groupement Hospitalier EST - Hospices Civils de Lyon, Bron, France
RETR(Osteomyelitis)
- Conditions
- Osteomyelitis
- Interventions
- Other: patients having had an osteomyelitis since 2017
- First Posted Date
- 2021-06-23
- Last Posted Date
- 2023-04-13
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 50
- Registration Number
- NCT04936958
- Locations
- 🇫🇷
Hospices Civils de Lyon, Lyon, France
Pharmacokinetics and Toxicodynamics of Daptomycin in Bone and Joint Infections
- Conditions
- Dactinomycin Adverse ReactionBone and Joint Infection
- Interventions
- Other: patients having had BJI or PJI treated with daptomycin
- First Posted Date
- 2021-06-21
- Last Posted Date
- 2022-05-06
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 1130
- Registration Number
- NCT04933344
- Locations
- 🇫🇷
Hospices Civils de Lyon, Lyon, France
The circTeloDIAG: Liquid Biopsy for Glioma Tumor
- Conditions
- Glioma
- Interventions
- Biological: ctDNA analysis
- First Posted Date
- 2021-06-18
- Last Posted Date
- 2023-10-11
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 150
- Registration Number
- NCT04931732
- Locations
- 🇫🇷
East Group Hospital, Hospices Civils de Lyon, Bron, France
Evaluation of Memory and Forgetting in Patients with Epilepsy
- Conditions
- Epilepsy
- Interventions
- Diagnostic Test: Computerised associative memory task using abstract words and landscape photographs
- First Posted Date
- 2021-06-14
- Last Posted Date
- 2025-01-06
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 80
- Registration Number
- NCT04924933
- Locations
- 🇫🇷
Hospices Civils de Lyon Service de Neurologie Fonctionnelle et d'Epileptologie, Bron, France
Cerebral and Autonomic Responses to Pain in Healthy Humans
- Conditions
- Nociceptive PainAnesthesiaHealthy
- Interventions
- Other: Nociceptive stimulation
- First Posted Date
- 2021-06-14
- Last Posted Date
- 2021-10-15
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 21
- Registration Number
- NCT04925336
- Locations
- 🇫🇷
Service de Neurologie Fonctionnelle et Epileptologie Hôpital Neurologique, GHE Hospices civils de Lyon, Bron, France
COVID-19 - SARS-CoV-2 Community Contamination in Children and Adults - Impact of Variants (Dyn3CEA - Nosocor Phase 2)
- Conditions
- Infection Viral
- Interventions
- Other: Phone call interviewOther: Review of medical file
- First Posted Date
- 2021-06-14
- Last Posted Date
- 2022-01-04
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 87
- Registration Number
- NCT04924842
- Locations
- 🇫🇷
Hôpital Femme Mère et enfant, Lyon, Auvergne Rhône Alpes, France
Fluoropyrimidine Tailored-dose Based on Uracil Concentration in Patients Treated for Digestive Carcinomas: Evaluation of Clinical Practice
- Conditions
- Digestive Carcinoma
- Interventions
- Drug: Fluoropyrimidine treatment (5-FU or capecitabine) and dosageOther: Uracil dosageBehavioral: Overall survival
- First Posted Date
- 2021-06-08
- Last Posted Date
- 2021-06-08
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 334
- Registration Number
- NCT04918264
- Locations
- 🇫🇷
Centre Hospitalier de Lyon Sud, Pierre-Bénite, France
🇫🇷Hopital Edouard Heriot, Centre Hospitalier de Lyon Sud [Lyon], Hopital de la Croix Rousse [Lyon], Lyon, France
🇫🇷Hopital de la Croix Rousse, Lyon, France